BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) Is The Most Active On NASDAQ During Morning Trading Hours

BioSante shares soar after study results

Dallas, TX 8/13/2009 09:08 PM GMT (TransWorldNews)

Dallas, TX - is a penny stock newsletter that is pleased to alert investors of top stocks on the move.

BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) is currently the top mover in the morning trade session. The stock is trading at $2.36, rallied 32.59% on very unusual volume of 1.40 million shares after the company said its lead candidate LibiGel to treat female sexual dysfunction was safe in the late-stage cardiovascular and breast cancer safety study.

BioSante Pharmaceuticals, Inc. announced positive safety data in its ongoing LibiGel Phase III clinical development program. BioSante reported that with over 1,250 women enrolled and almost 825 women years of exposure in its LibiGel Phase III clinical development program, there have been no deaths and only five cardiovascular events. This analysis of blinded data indicates a very low cardiovascular event rate has occurred thus far. The Phase III Cardiovascular and Breast Cancer Safety Study is a randomized, double blind, placebo controlled, multi center, cardiovascular events and breast cancer study that will enroll between 2,400 and 3,100 women, exposed to LibiGel or placebo for 12 months. In addition to the Phase III cardiovascular and breast cancer safety study, BioSante is conducting two LibiGel Phase III efficacy trials. The Phase III efficacy trials of LibiGel in the treatment of FSD are double-blind, placebo-controlled trials that will enroll up to approximately 500 surgically menopausal women each for a six-month clinical trial.

Biosante Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing products for female sexual health, menopause, contraception and male hypogonadism. The Company primary products include gel formulations of testosterone and estradiol. It is also engaged in the development of its calcium phosphate nanotechnology (CaP), primarily for aesthetic medicine, vaccines and drug delivery. The Company’s principal products include LibiGel, Bio-T-Gel and Pill-Plus. The Company’s CaP products in development include BioLook, BioVant, BioOral and BioAir.

Super Hot Penny Stocks alerts its members on stocks that could generate higher than average returns. These include stocks with huge volume, penny stocks that are moving to the upside quickly, penny stocks with buy signals and companies with news. Our alerts are well known for producing incredible results in a short amount of time and our members have made outstanding profits of over 100%.


ABOUT Super Hot Penny Stocks is a leading stock web site that provides free alerts on stocks that are poised to make big gains. also tracks small cap penny stocks that could be on the brink of a massive breakout. To feature a company on our web site please contact us at info@


Super Hot Penny Stocks is an independent electronic publication that provides information on selected publicly traded companies. Super Hot Penny Stocks is not a registered investment advisor or broker-dealer. Super Hot Penny Stocks affiliates, officers, directors and employees may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.


News Alerts

Receive alerts for BPAX to your inbox. Sign up for News Alerts

Empty Image

TransWorldNews, Inc. and its affiliate sites disclaim all liability for information and content provided by clients and appearing within their news and press releases.

Empty Image